Novartis Ag (NVS) Other Gross PP&E Adjustments (2016 - 2025)

Novartis Ag's Other Gross PP&E Adjustments history runs 10 years deep, the most recent figure standing at $8.9 billion for Q2 2025.

• In Q2 2025, Other Gross PP&E Adjustments rose 13.29% year-over-year to $8.9 billion; the TTM figure through Jun 2025 stood at $8.9 billion (up 13.29% YoY), while the FY2024 annual figure was -$27.0 million, down 1450.0% from the prior year.
• Other Gross PP&E Adjustments came in at $8.9 billion for Q2 2025 at Novartis Ag, up from -$27.0 million in the prior quarter.
• In the past five years, Other Gross PP&E Adjustments ranged from a high of $10.0 billion in Q4 2021 to a low of -$57.1 billion in Q2 2021.
• A 5-year average of -$4.5 billion and a median of $2.0 million in 2023 frame the typical range for Other Gross PP&E Adjustments.
• Across the five-year window, Other Gross PP&E Adjustments jumped 166500.0% in 2021 and slumped 13400.0% in 2023, its largest moves.
• Novartis Ag's Other Gross PP&E Adjustments stood at $10.0 billion in 2021, then decreased by 6.52% to $9.3 billion in 2022, then plunged by 99.98% to $2.0 million in 2023, then tumbled by 1450.0% to -$27.0 million in 2024, then jumped by 33188.89% to $8.9 billion in 2025.
• According to Business Quant data, Other Gross PP&E Adjustments over the past three periods registered $8.9 billion, -$27.0 million, and -$28.0 million for Q2 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison